About the Company
theseus pharmaceuticals is passionately committed to outsmarting cancer resistance. cancer is constantly mutating, allowing it to evade initially effective oncology treatments. theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance. led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (tkis), we are developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $THRX News
What Makes Theseus Pharmaceuticals, Inc. (THRX) a New Buy Stock
Theseus Pharmaceuticals, Inc. (THRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings ...
IDRx Appoints David P. Kerstein, M.D., as Chief Medical Officer
Prior to joining IDRx, Dr. Kerstein served as Chief Medical Officer of Theseus Pharmaceuticals, Inc., where he led the clinical development of the Company’s lead program for GIST. Before Theseus ...
ABOS Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer’s disease. The company focuses on advancing a targeted ...
Rock Springs Capital Master Fund LP's Net Worth
Who is Rock Springs Capital Master Fund LP? Rock Springs Capital Master Fund LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares ...
Elite Pharmaceuticals, Inc. (ELTP)
Elite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call Transcript February 15, 2024 Elite Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...
Vertex Pharmaceuticals Inc VRTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
TAKEDA PHARMACEUTICAL CO LTD's Net Worth
Who is TAKEDA PHARMACEUTICAL CO LTD? TAKEDA PHARMACEUTICAL CO LTD has an estimated net worth of $461 Million. This is based on reported shares across multiple companies, which include Calithera ...
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...
XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical ...
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead ...
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi ...
Loading the latest forecasts...